Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.
about
The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapySingle Nucleotide Polymorphisms in Cellular Drug Transporters Are Associated with Intolerance to Antiretroviral Therapy in Brazilian HIV-1 Positive IndividualsMitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients.Lack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional studyGenetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.Pharmacogenomics of antimicrobial agents.Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in NigeriaNutrigenomics and personalized diets: What will they mean for food?New and emerging agents in the management of lipodystrophy in HIV-infected patients.Individualization of antiretroviral therapy.Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot studyMitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiationPharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathyMitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapyLong term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity.Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults.
P2860
Q27027887-F13711CD-1EA7-447C-B572-8C1F58103B38Q28554250-B98B1F76-1883-4119-A080-5C30662FF090Q33896809-C50000A4-F6DE-4B4E-9B2E-0403492CAF4BQ34039225-38E29D9E-542B-43B8-A19A-90C4AFF0FB18Q34075188-82CEF2A4-4398-4B42-A050-881395211D82Q34372631-8AC6E230-4284-4AE4-B78E-14D4D7A5F464Q34772825-E0463D51-7FFB-4D49-B9DF-701C158EBA5DQ34977413-83C9D61A-2E35-4D47-88CE-011663ECA68CQ35187774-C2127E4B-8E24-416E-9558-9C92D1A5CEAEQ35551472-D9D9A8A9-5895-45E1-896A-F83213D52B0FQ35557229-725FF92C-CC2D-4628-8CE9-F5AAE2C7ECCFQ36441423-C3172E71-4EC2-47CD-ACB3-07061CC2C430Q36653563-74E325B8-1E76-4C9C-81B8-FCC55C17379EQ36937849-574FF1AD-6E7D-49CA-B866-C45F89FBD59BQ37204095-09F25369-8F33-4F0F-AA51-3CF26AD8BB0FQ37251569-B8EB1553-B03C-4BB8-A0B7-602F53835A98Q37344333-CC891386-7126-4E02-9B2C-46C70B440286Q37634512-FCBFBA85-610E-4ED4-B0BC-09AA0A49B3F4Q37720716-D67C80D7-1BA2-4CE4-8DE0-13C50F58C766Q37945715-00368C8A-84FF-48BA-B945-D2149D91DC8EQ40097257-B5AEBB35-3985-4A3C-A769-63D92BA027BEQ41756147-2776D54E-F19C-43BC-8DF2-7984B4AEB4E0
P2860
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Hemochromatosis gene polymorph ...... during antiretroviral therapy.
@en
Hemochromatosis gene polymorph ...... during antiretroviral therapy.
@nl
type
label
Hemochromatosis gene polymorph ...... during antiretroviral therapy.
@en
Hemochromatosis gene polymorph ...... during antiretroviral therapy.
@nl
prefLabel
Hemochromatosis gene polymorph ...... during antiretroviral therapy.
@en
Hemochromatosis gene polymorph ...... during antiretroviral therapy.
@nl
P2093
P356
P1476
Hemochromatosis gene polymorph ...... during antiretroviral therapy.
@en
P2093
AIDS Clinical Trials Group 384 and A5005s Study Teams
Alison A Motsinger
Asha R Kallianpur
David W Haas
Gregory K Robbins
Jeffrey A Canter
Kathleen Mulligan
Michael Dubé
Steven Grinspoon
Todd Hulgan
P304
P356
10.1086/528697
P407
P50
P577
2008-03-01T00:00:00Z